Pertussis Epidemiology in the Autonomous Province of Vojvodina, Serbia, 1948–2023
Author:
Ristić Mioljub12ORCID, Medić Snežana12, Vuković Vladimir12ORCID, Rajčević Smiljana12, Koprivica Marko2, Banjac Jelena3ORCID, Ljubičić Stefan2, Petrović Vladimir12ORCID
Affiliation:
1. Department of Epidemiology, Faculty of Medicine, University of Novi Sad, 21000 Novi Sad, Serbia 2. Institute of Public Health of Vojvodina, 21000 Novi Sad, Serbia 3. Public Health Institute Subotica, 24000 Subotica, Serbia
Abstract
Pertussis continues to be a significant public health concern. We aimed to examine the epidemiological characteristics of pertussis in Vojvodina, which accounts for almost a third of Serbia’s population. Our aim was to determine the overall and age-specific incidence and mortality rates of pertussis in Vojvodina from 1948 to 2023, as well as the coverage of immunization against pertussis from 1960 to 2023. In the period 1948–2023, 42,259 cases of pertussis were reported. Following the introduction of the DTwP vaccine (1960) in Serbia, the reported incidence of pertussis began to decline. In 2001, for the first time since introduction of pertussis surveillance in Vojvodina, no pertussis cases were reported. Since 2012, the reported incidence of pertussis has once again increased, and peaked (41.1/100,000) in 2023, approaching the incidence rates recorded shortly after the introduction of DTwP vaccine. A shift in the age profile of pertussis from children aged 0–6 years to school-aged children (7–14 years) occurred between 2012 and 2023, when 48.3% of pertussis cases occurred in this age group. Although the incidence rates of pertussis among individuals aged 20 years and older were significantly lower than among younger age groups, there is evidence of an increasing trend in pertussis cases, particularly among those aged 40–49 years, since 2012. Based on the findings of this study, it is imperative to introduce additional booster doses of the aP vaccine for individuals aged 14 years, along with implementing maternal immunization strategies targeting women of childbearing age.
Reference42 articles.
1. World Health Organization (2016). Pertussis vaccines: WHO position paper, August 2015—Recommendations. Vaccine, 34, 1423–1425. 2. Pertussis epidemiology in Canada, 2005–2019;Bhagat;Can. Commun. Dis. Rep.,2023 3. European Centre for Disease Prevention and Control (ECDC) (2016). Pertussis—Annual Epidemiological Report 2016, ECDC. 4. Waning Immunity After Receipt of Pertussis, Diphtheria, Tetanus, and Polio-Related Vaccines: A Systematic Review and Meta-analysis;Gao;J. Infect Dis.,2022 5. Bagordo, F., Grassi, T., Savio, M., Rota, M.C., Baldovin, T., Vicentini, C., Napolitano, F., Trombetta, C.M., Gabutti, G., and Seroepidemiological Study Group (2023). Assessment of Pertussis Underreporting in Italy. J. Clin. Med., 1a2.
|
|